However, the widespread expression of RYR3 in the human body cannot explain how its variants lead to DEE or myopathy, two completely different clinical phenotypes, and there have been no reports of individuals having both epilepsy and myopathy. Here, RYR3 is linked to developmental and epileptic encephalopathy.